OnCall

Operational Pathways for Biomarker Testing in NSCLC

In this Amgen sponsored podcast, David R. Braxton, MD, Chief of Service for Molecular Pathology at Hoag Hospital, shares his insights as considerations on operationalizing biomarker testing into clinical practice in NSCLC. He discusses considerations on improving the turnaround time of test results, clinical application of ctDNA testing as well as strategies for documentation of results for ease of retrieval. 

Sponsored by Amgen

If you have any questions for today’s guests, or have a topic you would like to hear more about, email OnCall@cencora.com.